Showing 1 - 8 results of 8 for search 'Zhengchao Tu', query time: 0.03s Refine Results
  1. 1
    Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells

    Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells by Yingjun Li, Yongjun Huang, Huimin Cheng, Fang Xu, Ruxi Qi, Botao Dai, Yujian Yang, Zhengchao Tu, Lijie Peng, Zhang Zhang

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Rapid detection of traditional Chinese medicine with neuraminidase inhibitory activities based on high-throughput and virtual screening strategy

    Rapid detection of traditional Chinese medicine with neuraminidase inhibitory activities based on high-throughput and virtual screening strategy by Yuheng Huang, Zhen Wang, Senbiao Fang, Ying Tan, Jiajun Chen, Jiaming Xie, Zhengchao Tu, Weihuan Huang, Ning Li, Haiyan Tian

    Published 2023-02-01
    Get full text
    Article
  3. 3
    YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFRL858R, T790M‐mutant resistance in vitro and in vivo

    YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFRL858R, T790M‐mutant resistance in vitro and in vivo by Zhang Zhang, Jian Zou, Lei Yu, Jinfeng Luo, Yan Li, Zhengchao Tu, Xiaomei Ren, Hongcheng Wei, Liyan Song, Xiaoyun Lu, Ke Ding

    Published 2018-04-01
    Get full text
    Article
  4. 4
    GZD824 overcomes FGFR1‐V561F/M mutant resistance in vitro and in vivo

    GZD824 overcomes FGFR1‐V561F/M mutant resistance in vitro and in vivo by Kaili Jiang, Xia Tang, Jing Guo, Rui He, Shingpan Chan, Xiaojuan Song, Zhengchao Tu, Yuting Wang, Xiaomei Ren, Ke Ding, Zhang Zhang

    Published 2021-07-01
    Get full text
    Article
  5. 5
    GZD824 as a FLT3, FGFR1 and PDGFRα Inhibitor Against Leukemia In Vitro and In Vivo

    GZD824 as a FLT3, FGFR1 and PDGFRα Inhibitor Against Leukemia In Vitro and In Vivo by Yuting Wang, Lenghe Zhang, Xia Tang, Jinfeng Luo, Zhengchao Tu, Kaili Jiang, Xiaomei Ren, Fang Xu, Shingpan Chan, Yuhua Li, Zhang Zhang, Ke Ding

    Published 2020-04-01
    Get full text
    Article
  6. 6
    JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo

    JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo by Jie Wang, Yang Zhou, Xia Tang, Xiuwen Yu, Yongjin Wang, Shingpan Chan, Xiaojuan Song, Zhengchao Tu, Zhimin Zhang, Xiaoyun Lu, Zhang Zhang, Ke Ding

    Published 2022-10-01
    Get full text
    Article
  7. 7
    Catalyst-free late-stage functionalization to assemble α-acyloxyenamide electrophiles for selectively profiling conserved lysine residues

    Catalyst-free late-stage functionalization to assemble α-acyloxyenamide electrophiles for selectively profiling conserved lysine residues by Yuanyuan Zhao, Kang Duan, Youlong Fan, Shengrong Li, Liyan Huang, Zhengchao Tu, Hongyan Sun, Gregory M. Cook, Jing Yang, Pinghua Sun, Yi Tan, Ke Ding, Zhengqiu Li

    Published 2024-02-01
    Get full text
    Article
  8. 8
    Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step.

    Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step. by Feng Yang, Moses M Njire, Jia Liu, Tian Wu, Bangxing Wang, Tianzhou Liu, Yuanyuan Cao, Zhiyong Liu, Junting Wan, Zhengchao Tu, Yaoju Tan, Shouyong Tan, Tianyu Zhang

    Published 2015-01-01
    Get full text
    Article

Search Tools: